Peptide Vendor Verification: 9 Checks Before You Order
Written by Jian Wang, Founder & CEO ·

Verifying a peptide vendor means confirming three things: that the lot you will receive has its own certificate of analysis, that an identifiable lab issued it, and that the data shows both purity and identity. Then you check the claim yourself with a sample sent to an independent lab. A clean website, a purity badge or a “research use only” label proves none of this.
This guide gives you the checks in the order we run them, the questions to put to a vendor, and the red flags that should end a conversation.
TL;DR
- Ask for a lot-specific CoA before you pay. A generic or template document is not evidence about your vial.
- Purity alone is not enough. You need HPLC for homogeneity and mass spectrometry for identity, with the raw chromatogram and spectrum.
- Check who ran the test. Look for a named lab, ideally accredited to ISO/IEC 17025, and confirm the accreditation yourself.
- “Research use only” is a legal disclaimer, not a quality mark. Dosing or treatment language on a research product is a red flag.
- The strongest verification is a blind, independent test of a product you bought yourself.
Table of Contents
- Why a vendor’s word is not verification
- The nine checks, in order
- Red flags that end the conversation
- Research use only is a boundary, not a badge
- What clinics and larger buyers should add
- Our perspective
- Shortcut: lab results for vendors you are considering
- A worked example: reading one CoA
- Keeping verification going after the first order
- FAQ
- Sources
Why a vendor’s word is not verification
Peptides are sold online by hundreds of businesses, and most buyers cannot see inside the vial. Two products can carry the same name, the same price per milligram and the same “99% pure” claim, and still differ in identity, total peptide content, contaminants and fill amount.
That is why verification has to rest on documents, records and samples rather than marketing. A supplier-audit checklist published in 2026 makes the same point: a website cannot show who manufactures the product, whether the CoA matches the batch, or whether the company can repeat an order. Those answers come from paperwork and direct questions.
The checks below are written for researchers, lab managers and procurement staff. Clinicians and pharmaceutical buyers should add their own regulatory and quality-agreement requirements on top.

The nine checks, in order
1. Is there a batch-specific CoA before you pay?
Open the product page and look for a certificate of analysis tied to a lot number. If the vendor says “available on request” and then sends a PDF that shows no lot number, move on. A certificate that cannot be matched to the vial label tells you nothing about the vial.
Your test is simple: the lot number on the CoA must match the lot number that will be printed on what arrives. If the vendor will not commit to that, you are buying a promise.
We go deeper on this in our guide to requiring a lot-specific CoA when vetting suppliers.
2. Who issued the CoA?
A CoA from the vendor’s own letterhead is a claim by the seller. A CoA from a named, separate laboratory with an address and a signatory is better, and one from an accredited lab is better still.
ISO/IEC 17025 is the international reference for testing laboratory competence. ISO’s conformity assessment materials explain that accreditation and similar schemes are how claims about products and services get demonstrated. In practice:
- Ask for the lab’s full name and accreditation number.
- Check the accreditation body’s public directory yourself. Do not rely on a logo pasted onto the PDF.
- Check that the accreditation scope covers the type of testing shown, not just some other analysis.
A vendor that relies only on in-house testing it cannot document lacks the independent basis a high-stakes research project needs.
3. Does the CoA carry both purity and identity?
These are two different questions. HPLC (or UPLC) tells you how homogeneous the sample is. Mass spectrometry tells you whether the main peak is the molecule on the label. The United States Pharmacopeia describes pharmaceutical-standard assessment of synthetic peptides as a series of analytical tests covering identity, purity and strength, not a single number.

A purity figure with no identity check proves far less than it appears to. A 99% pure sample of the wrong molecule is still the wrong molecule.
4. Can you see the raw data?
A percentage on a summary page is easy to type. A chromatogram and a mass spectrum are harder to fake and much easier to question. Ask for:
- The full HPLC trace, with the method (column, gradient, detection wavelength) and integration shown.
- The MS spectrum with the expected and observed mass.
- The sample ID, injection date and instrument.
When the same PDF layout, the same peak shape and the same date show up across unrelated products, treat it as a template. Our article on why 98% HPLC purity can be 75% peptide explains why a purity ratio says nothing about how much peptide is actually in the vial.
5. Is the CoA internally consistent?
Read it like a reviewer. Does the stated sequence match the product? Is the molecular weight right for the quantity? Does the test date fall before the manufacturing date? Is the lot number format the same as on the vials? Our three-check approach to peptide CoA interpretation walks through the traceability points in detail.
6. Does the business exist outside its website?
A vendor audit starts with basics. Confirm:
- A physical address that is not a mail drop or a residential unit.
- A registered business entity in the state or country it names, which you can look up in the public registry.
- A working phone number and an email on the company domain that someone answers.
- A named person who can answer technical questions about synthesis, storage and testing.
The point is accountability. If a lot fails, there should be someone you can reach.
7. Read how the product is marketed
The regulatory line is clear enough to use as a filter. In December 2024 the FDA sent warning letters to peptide sellers. The letter to Prime Vitality, Inc. dba Prime Peptides cites website content as evidence that products sold as research chemicals were intended for human use. A second letter issued the same day followed the same pattern.
The enforcement has continued. In September 2026 the FDA posted five more warning letters over semaglutide, tirzepatide, retatrutide and other peptides, including products labeled for research that the agency treated as intended for human drug use.
For you as a buyer, that means:
- Dosing schedules, “results” language, testimonials about body changes or injection instructions on a research product are red flags about the seller’s compliance and its judgment.
- A vendor that cuts corners on legal claims is more likely to cut them elsewhere.
- Buying from a business that may be shut down mid-project is a supply risk for any study.
We keep a running summary of the legal picture in our 2026 enforcement checklist for U.S. researchers.
8. Ask the audit questions
A short written questionnaire separates serious suppliers from resellers. Send these and keep the replies:
- Who synthesizes the peptide, and in which country?
- Which lab tests each lot, and is it accredited? Can I have the accreditation number?
- Will you supply the raw HPLC and MS files for the lot I am buying?
- How is each lot numbered, and how does that appear on the vial?
- What are your storage and shipping conditions (temperature, lyophilized form, packaging)?
- What do you do when a lot fails or a customer reports a mismatch? Is there a recall or replacement policy in writing?
- Do you retain samples from each lot?
- Can you document the business registration and a physical address?
Published vendor audit frameworks add quality-system questions for larger buyers, such as whether the supplier holds ISO 9001 certification, which is listed as a basic credential to confirm. Treat a missing answer as an answer. Slow, vague or defensive replies to simple questions predict how a dispute will go.
9. Test it yourself
Everything above is evidence the vendor chose to show you. The only evidence the vendor does not control is a sample you buy like any customer and send to an independent lab.
Do this:
- Buy the same lot you intend to use, through the normal checkout.
- Keep the vial sealed and note the lot number and the date received.
- Send it to an accredited lab for HPLC purity and MS identity. Ask for the raw files.
- Compare the lab’s results with the vendor’s CoA for the same lot.
- Record the result. Reorder only if it matches.
Our write-up on independent testing and a 27% CoA match shows why this step matters: vendor documents and independent results do not always agree. If you need the practical setup, see our guide to the three requirements for third-party peptide testing and the 20-minute purity check.
Red flags that end the conversation
| Signal | Why it matters |
|---|---|
| CoA with no lot number | It cannot be tied to your vial |
| Purity percentage only, no chromatogram | Easy to manipulate, no identity proof |
| No named lab, or only in-house testing | No independent check |
| Accreditation logo but no number | Cannot be verified |
| Dosing, injection or weight-loss claims on a research product | Regulatory exposure, as the FDA letters above show |
| No physical address or business registration | No accountability |
| Pressure tactics, countdown timers, “limited stock” | Marketing, not quality |
| Refuses to supply raw data | Nothing to inspect |
Research use only is a boundary, not a badge
Many buyers read “for research use only” as a seal of approval. It is closer to the opposite: a legal statement that the product is not approved for human consumption. As the FDA letters show, regulators examine how a product is actually promoted, and the label does not shield a seller who markets it for human use. So the label tells you the intended legal category and nothing about whether the vial contains what it says.
Health note: if you are a patient rather than a researcher, an unapproved product from a research vendor is not a substitute for a prescribed, approved medicine. Talk to your physician or pharmacist about approved options and do not use research-labeled material for yourself.
What clinics and larger buyers should add
Clinical and institutional buyers face stricter obligations than a bench researcher. They should require a supplier qualification file, written quality agreements, lot-by-lot HPLC and MS verification and a defined process for deviations. Our guide to clinical peptide sourcing and lot verification covers this. Regulatory questions about which products a clinic may lawfully use belong with your counsel and the relevant regulator, not with a vendor.
Our perspective
We built Borenhealth because the same problem kept appearing: the information a buyer needs most is the information a seller has the least reason to share. Vendor-supplied CoAs are produced by the party that benefits from a good result.
So we do not rely on them. Our vendor purity and identity data come from blind sample purchases and third-party lab testing, and we publish every result, including failures. We do not sell peptides, and rankings are not influenced by pay-to-rank or advertising. We are open about how we make money: we are an affiliate marketplace, and we may earn a referral commission when a reader buys from a vendor after using our comparison. That is why the methodology is public and why failures stay visible.
If we had one piece of advice for a first-time buyer, it would be this: never let a single number decide. A purity percentage, a price per milligram or a review score each answers one question. Verification means asking all of them, then checking the answer with a vial you bought yourself.
— Ross
Shortcut: lab results for vendors you are considering
Running blind purchases and lab tests for every candidate vendor is slow and costly. We do it so you can start from data. Our peptide purity page shows lab results for each peptide, and our goal-based rankings order vendors by lab results across categories such as weight loss, healing and recovery, skin and gut health. Use them to shortlist, then apply the nine checks above to your own lot. If you want to compare cost per milligram, see the peptide price list, which is updated daily.
Are you a vendor? Plans start at $150 per month, and testing costs $100 per sample, one-off. Details are on our vendor page. Paying does not change how a vendor ranks.
A worked example: reading one CoA
Suppose a vendor sends a PDF for a tirzepatide lot. Here is how you would work through it.
- Header. Is there a lab name, address and accreditation number? If only the vendor’s logo appears, mark it as a self-issued document.
- Lot and date. Does the lot number match the product page and the order confirmation? Is the test date after synthesis and before shipment?
- Identity. Is there an MS result with the expected and observed mass? If the molecule has a known molecular weight, check that the stated mass is plausible.
- Purity. Is there a chromatogram? Is the main peak clearly resolved? Are small impurity peaks visible, or is the baseline suspiciously flat?
- Content. Does the document say anything about net peptide content or fill amount? A purity ratio says nothing about how many milligrams are in the vial.
- Method. Are the column, gradient and detection wavelength named? A result with no method cannot be reproduced.
- Consistency. Does the same lab report look identical for unrelated products, down to the peak shape? Template documents often give themselves away this way.
If the CoA passes, you have a reasonable basis to buy a small quantity and run your own test. If it fails two or more steps, stop. The cost of an extra email is tiny compared with the cost of a failed experiment or a contaminated study.
Keeping verification going after the first order
Verification is not a one-time event. Lots change, and so do vendors. A routine that works for most labs:
- Re-test at least one lot per quarter, and always after a change in supplier, packaging or appearance.
- Keep a log of lot numbers, CoAs, your own test results and delivery conditions.
- Store samples as the vendor and the manufacturer specify, and record how long they sat in transit.
- Set a pass rule in advance, for example an identity match plus a purity threshold you define for your application, so that results are judged against a standard rather than hindsight.
- Share findings with your purchasing team so that one failed lot closes the supplier for everyone.
FAQ
How do I tell if a peptide vendor is legit?
Check for a lot-specific CoA from a named laboratory, with both HPLC purity and mass spectrometry identity and the raw data behind them. Confirm the business address and registration, and read the marketing for dosing or treatment claims. Then test a sample you bought yourself at an independent lab.
Is a high purity percentage enough?
No. Purity is a ratio of peaks and does not confirm the molecule’s identity or how much peptide is in the vial. The USP’s approach to peptide quality combines chromatography for homogeneity with mass spectrometry for identification, so you should ask for both.
Does “research use only” mean a vendor is approved or regulated?
No. It is a legal disclaimer that the product is not approved for human use, and the FDA has issued warning letters to sellers whose other marketing showed human-use intent. It says nothing about quality.
Do I need an accredited lab to test a peptide?
You do not need one by law for your own checking, but an ISO/IEC 17025 accredited lab gives you a documented standard of competence and traceability. Ask for the accreditation number and check it with the accrediting body, and ask for raw chromatograms and spectra along with the report.
How often should I re-verify a vendor?
Test the first lot you buy, then re-test periodically and whenever the lot, appearance or packaging changes. A vendor that passed last year can fail today, so keep the process running.
Sources
- FDA warning letter: Prime Vitality, Inc. dba Prime Peptides (December 10, 2024)
- FDA warning letter: Summit Research Peptides (December 10, 2024)
- FDA issues five warning letters over peptide and GLP-1-related products
- USP: Reference standards to support quality of synthetic peptide therapeutics
- ISO CASCO: Delivering supply chain confidence
- Peptide supplier audit: B2B checklist
- Peptide supplier audit framework